Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$473K Buy
1,879
+12
+0.6% +$2.58K 0.04% 113
2026
Q1
$427K Hold
1,867
0.04% 104
2025
Q4
$427K Buy
1,867
+189
+11% +$43.1K 0.04% 113
2025
Q3
$311K Sell
1,678
-245
-13% -$49.9K 0.03% 114
2025
Q2
$403K Hold
1,923
0.05% 101
2025
Q1
$342K Buy
1,923
+560
+41% +$109K 0.04% 115
2024
Q4
$269K Hold
1,363
0.03% 128
2024
Q3
$234K Hold
1,363
0.03% 120
2024
Q2
$248K Hold
1,363
0.03% 117
2024
Q1
$248K Hold
1,363
0.03% 120
2023
Q4
$211K Buy
+1,363
New +$199K 0.03% 123

Other funds holding ABBV

KWB Wealth's ABBV Position: Q2 2026 in Review

KWB Wealth increased its AbbVie (ABBV) stake by 0.64% in Q2 2026, buying an estimated $2.58K and bringing the position to 1,879 shares worth $473K. The position accounts for 0.04% of the portfolio, ranked #113.

KWB Wealth first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • KWB Wealth held 1,879 shares of AbbVie worth $473K as of Q2 2026.
  • KWB Wealth bought 12 AbbVie shares in Q2 2026, an estimated $2.58K.
  • AbbVie made up 0.04% of KWB Wealth's portfolio in Q2 2026, its #113 holding.
  • KWB Wealth first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on KWB Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.